Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Disease × Bevacizumab × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 38 Carcinoma, Hepatocellular 15 Ovarian Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Glioblastoma 3 Uterine Cervical Neoplasms 2 Endometrial Neoplasms 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Brain Neoplasms 2 mCRC 1 Unresectable Metastatic Colorectal Cancer 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1 Rectal Neoplasms Malignant 1 Ras-mutated Metastatic Colorectal Cancer 1 Proteinuria 1 Platinum-sensitive Relapsed Ovarian Cancer 1 Platinum-resistant Recurrent Ovarian Cancer (PROC) 1 Platinum-resistant Recurrent Ovarian Cancer 1 Osteosarcoma 1 Non-small Cell Lung Cancer Patients with Brain Metastases 1 Neutropenia 1 Neoplastic Cells, Circulating 1 Nasopharyngeal Carcinoma 1

Interventions

Tomography, X-Ray Computed 2 Colonoscopy 2 gilteritinib 1 Surveys and Questionnaires 1 Standard of Care 1 Sequence Analysis, RNA 1 Preoperative Exercise 1 Nutritional Status 1 Nutrition Assessment 1 Methods 1 Liquid Biopsy 1 Hysterectomy 1 Exercise 1 Endoscopy 1 Educational Status 1 Drug Therapy 1 Diagnostic Tests, Routine 1 DNA 1 Capecitabine 1 Bupivacaine 1 Bevacizumab 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07134101 2025-08-29

SMARTi-RC01

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting

Gastrointestinal

Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡